Infimer Stock Fundamentals
| INFR-M Stock | 199.10 0.20 0.10% |
Infimer fundamentals help investors to digest information that contributes to Infimer's financial success or failures. It also enables traders to predict the movement of Infimer Stock. The fundamental analysis module provides a way to measure Infimer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infimer stock.
Infimer |
Infimer Company Shares Owned By Institutions Analysis
Infimer's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Infimer Shares Owned By Institutions | 10.03 % |
Most of Infimer's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infimer is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 10.03% of Infimer are shares owned by institutions. This is much higher than that of the sector and significantly higher than that of the Shares Owned By Institutions industry. The shares owned by institutions for all Israel stocks is notably lower than that of the firm.
Infimer Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Infimer's current stock value. Our valuation model uses many indicators to compare Infimer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infimer competition to find correlations between indicators driving Infimer's intrinsic value. More Info.Infimer is currently regarded as number one stock in return on asset category among its peers. It is rated fifth overall in shares owned by insiders category among its peers making about 13.62 of Shares Owned By Insiders per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value Infimer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infimer's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Infimer Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infimer's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infimer could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics of similar companies.Infimer is currently under evaluation in shares owned by institutions category among its peers.
Infimer Fundamentals
| Return On Asset | 0.49 | |||
| Shares Owned By Insiders | 6.64 % | |||
| Shares Owned By Institutions | 10.03 % | |||
| Revenue | 350 K | |||
| Gross Profit | (401 K) | |||
| EBITDA | 1.5 M | |||
| Book Value Per Share | (4.63) X | |||
| Earnings Per Share | (0.59) X | |||
| Beta | 1.62 |
About Infimer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infimer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infimer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infimer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.